These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Serum lipid studies in women using combination type of oral contraceptives. Vaidya R; Purandare VN; Nain S; Gupta K; Rajwade N; Sheth UK J Obstet Gynaecol India; 1979 Jun; 29(3):644-6. PubMed ID: 12335922 [TBL] [Abstract][Full Text] [Related]
45. Insulin resistance, secretion, and metabolism in users of oral contraceptives. Godsland IF; Walton C; Felton C; Proudler A; Patel A; Wynn V J Clin Endocrinol Metab; 1992 Jan; 74(1):64-70. PubMed ID: 1530790 [TBL] [Abstract][Full Text] [Related]
46. Population-based study of risk of venous thromboembolism associated with various oral contraceptives. Farmer RD; Lawrenson RA; Thompson CR; Kennedy JG; Hambleton IR Lancet; 1997 Jan; 349(9045):83-8. PubMed ID: 8996419 [TBL] [Abstract][Full Text] [Related]
47. Interindividual variation and drug interactions with hormonal steroid contraceptives. Back DJ; Breckenridge AM; Crawford FE; MacIver M; Orme ML; Rowe PH Drugs; 1981 Jan; 21(1):46-61. PubMed ID: 7009137 [TBL] [Abstract][Full Text] [Related]
48. [Immunoglobulins and hormonal contraception]. Fassati P; Motejlová A; Oktábcová M; Spízek J; Fassati M Cesk Gynekol; 1983 Aug; 48(7):475-9. PubMed ID: 6627427 [TBL] [Abstract][Full Text] [Related]
49. The effects of oestrogen administration on the plasma free protein S and C4b-binding protein. Melissari E; Kakkar VV Thromb Res; 1988 Mar; 49(5):489-95. PubMed ID: 2967557 [TBL] [Abstract][Full Text] [Related]
50. Androgenic effects of oral contraceptives: implications for patient compliance. Jones EE Am J Med; 1995 Jan; 98(1A):116S-119S. PubMed ID: 7825631 [TBL] [Abstract][Full Text] [Related]
51. Exogenous progestins and breast cancer. Stanford JL; Thomas DB Epidemiol Rev; 1993; 15(1):98-107. PubMed ID: 8405216 [TBL] [Abstract][Full Text] [Related]
52. [Oral contraception: evolution of concepts over the last thirty years]. Belaisch J; Hommais-loufrani B Contracept Fertil Sex (Paris); 1987 Nov; 15(11 Suppl):1-8. PubMed ID: 12281408 [TBL] [Abstract][Full Text] [Related]
53. Impairment of caffeine clearance by chronic use of low-dose oestrogen-containing oral contraceptives. Abernethy DR; Todd EL Eur J Clin Pharmacol; 1985; 28(4):425-8. PubMed ID: 4029248 [TBL] [Abstract][Full Text] [Related]
57. [Hepatic changes caused by contraceptive steroids]. Uribe M; de Uribe MH; Carío AA Rev Gastroenterol Mex; 1977; 42(3):139-47. PubMed ID: 616980 [TBL] [Abstract][Full Text] [Related]
58. Thrombotic diseases in young women and the influence of oral contraceptives. Lidegaard O Am J Obstet Gynecol; 1998 Sep; 179(3 Pt 2):S62-7. PubMed ID: 9753312 [TBL] [Abstract][Full Text] [Related]
59. Focal nodular hyperplasia of the liver and contraceptive steroids. St Omer FB; Iozzo RV; Casetti P; Dellarolle AC Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):319-21. PubMed ID: 696209 [TBL] [Abstract][Full Text] [Related]
60. The effect of contraceptive steroids on hypothalamic-pituitary function. Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]